11 studies found for:    implantable cardioverter defibrillator OR ICD | Open Studies | NIH, U.S. Fed
Show Display Options
Rank Status Study
1 Not yet recruiting Efficacy and Safety of ICD Implantation in the Elderly
Conditions: Cardiomyopathy;   Coronary Artery Disease;   Congestive Heart Failure;   Myocardial Infarction
Interventions: Device: Implantable Cardioverter Defibrillator;   Other: Optimal standard of care
2 Recruiting Positive Therapy for Autonomic Function & Mood in ICD Patients
Conditions: Ventricular Arrhythmia;   Implantable Cardioverter Defibrillator
Interventions: Behavioral: Quality of Life Therapy (QOLT);   Behavioral: Heart Healthy Education (HHE)
3 Recruiting An Intervention to Improve Implantable Cardioverter-Defibrillator Deactivation Conversations
Conditions: Communication;   Heart Failure
Interventions: Behavioral: Communication training for cardiologists.;   Other: Control arm
4 Recruiting Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention
Conditions: Heart Failure, Congestive;   Death, Sudden, Cardiac;   Arrhythmia;   Cardiomyopathies
Intervention:
5 Unknown  Stress Reduction Program to Reduce Abnormal Heart Rhythms Treated With Implantable Cardioverter Defibrillators (The RISTA Study)
Condition: Arrhythmias, Cardiac
Intervention: Behavioral: Stress reduction treatment (SRT) program
6 Recruiting A Study of Symptoms and Quality of Life in Patients With Implantable Cardiac Defibrillators (ICDs) and Their Caregivers
Conditions: Quality of Life;   Implantable Cardiac Defibrillators;   ICDs
Intervention: Behavioral: Quality of life
7 Unknown  Inflammation, Cardiac Sympathetic Innervation, and Arrhythmic Sudden Death
Conditions: Ischemic Cardiomyopathy;   Dilated Cardiomyopathy;   Inflammation;   Sudden Cardiac Death
Intervention:
8 Recruiting A Phase I Trial of T Cells Expressing an Anti-GD2 Chimeric Antigen Receptor in Children and Young Adults With GD2+ Solid Tumors
Conditions: Sarcoma;   Osteosarcoma;   Rhabdomyosarcoma;   Neuroblastoma;   Melanoma
Interventions: Biological: Anti-GD2-CAR engineered T cells;   Drug: AP1903;   Drug: Cyclophosphamide
9 Not yet recruiting Interstitial Lung Diseases in the Veterans Administration
Condition: Interstitial Lung Disease
Intervention:
10 Recruiting INCB024360 Before Surgery in Treating Patients With Newly Diagnosed Stage III-IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Conditions: Stage IIIA Fallopian Tube Cancer;   Stage IIIA Ovarian Cancer;   Stage IIIA Primary Peritoneal Cancer;   Stage IIIB Fallopian Tube Cancer;   Stage IIIB Ovarian Cancer;   Stage IIIB Primary Peritoneal Cancer;   Stage IIIC Fallopian Tube Cancer;   Stage IIIC Ovarian Cancer;   Stage IIIC Primary Peritoneal Cancer;   Stage IV Fallopian Tube Cancer;   Stage IV Ovarian Cancer;   Stage IV Primary Peritoneal Cancer
Interventions: Drug: IDO1 Inhibitor INCB024360;   Other: Laboratory Biomarker Analysis;   Procedure: Therapeutic Conventional Surgery
11 Recruiting Systemic Sclerosis (SSc) Vasculopathy: Improved Clinical Monitoring and Treatment
Condition: Rheumatologic Disease
Interventions: Drug: BH4;   Other: Vasculopathy assessment;   Drug: Placebo

Indicates status has not been verified in more than two years